Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/22/2012US8183229 Bone filling complex and method for fabricating the same
05/22/2012US8183228 Anticoagulant antithrombotic dual inhibitors comprising a biotin label
05/22/2012US8183226 Myocardial perfusion imaging method
05/22/2012US8183225 Inhibition of bone resorption using medical implants containing adenosine receptor antagonists
05/22/2012US8183224 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
05/22/2012US8183222 Method to inhibit cell growth using oligonucleotides
05/22/2012US8183219 Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
05/22/2012US8183216 Nucleoside derivatives as inhibitors of viral polymerases
05/22/2012US8183215 Method of administering oral flora-improving agent, antibacterial agent and growth promoter
05/22/2012US8183214 Cell surface coating with hyaluronic acid oligomer derivative
05/22/2012US8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
05/22/2012US8183209 Treatment of T-cell mediated diseases
05/22/2012US8183208 Targeted delivery of drugs for the treatment of viral infections
05/22/2012US8183206 Particularly 3-methyl-1-phenyl-2-pyrazolin-5-one; thrombolytic agent, an anticoagulant and/or a platelet aggregation inhibitory agent such as a thromboxane synthetase inhibitor; for treating and/or preventing ischemic diseases which are safe and have few side effects
05/22/2012US8183203 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide
05/22/2012US8182996 Compositions and methods for detecting Klebsiella pneumoniae
05/22/2012US8182838 Dry powder composition comprising co-jet milled particles for pulmonary inhalation
05/22/2012US8182837 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
05/22/2012US8182836 Abuse-resistant oral dosage forms and method of use thereof
05/22/2012US8182835 Sustained-release liposomal anesthetic compositions
05/22/2012US8182833 Method and kit for reducing the symptoms of peripheral vascular disease with topical progesterone
05/22/2012US8182831 For encapsulating an unstable drug and/or a drug with unpleasant taste, drug entrapped in pores of grains
05/22/2012US8182824 Ciclesonide-containing sterile aqueous suspension
05/22/2012US8182802 Cationic block polymers containing 2-methacyloyloxyethyl-2,1-trimethyl ammonium ethyl phosphate liner salt with DNA; drug delivery
05/22/2012US8182801 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
05/22/2012US8182799 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
05/22/2012US8182795 Oil-in-water emulsion type sunscreen preparation
05/22/2012US8182794 Sunless tanning products and processes
05/22/2012US8182793 Composition with 1,2-pentanediol for low odor and dihydroxyacetone with moisturizers, sodium lactate or lactic acid for tanning skin
05/22/2012US8182791 Free-flowing fine particle mixtures comprising carrier particles, active drug particles and stabilizer particles, for respiratory system disorders; medical equipment
05/22/2012US8182527 Heparin barrier coating for controlled drug release
05/22/2012US8182464 Method for intravesical drug delivery
05/22/2012CA2716268C Composition and method for irrigation of a prepared dental root canal
05/22/2012CA2683696C Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity
05/22/2012CA2681136C Heterocyclic compounds and their uses
05/22/2012CA2656415C Novel pyridazine compound and use thereof
05/22/2012CA2648036C Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
05/22/2012CA2632949C Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
05/22/2012CA2628490C 5-lipoxygenase-activating protein (flap) inhibitors
05/22/2012CA2614667C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/22/2012CA2592069C A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/22/2012CA2571649C Pharmaceutical compositions containing a selective and specific sinus node if current inhibitor and a calcium inhibitor, and their use
05/22/2012CA2571397C 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
05/22/2012CA2561828C Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases
05/22/2012CA2560642C 5-aminoalkylpyrazole derivatives as pesticidal agents
05/22/2012CA2546302C Combination of flupirtine and tramadol
05/22/2012CA2540501C Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
05/22/2012CA2536135C Multivitamin syrup for children or young adults
05/22/2012CA2533791C Medicaments for inhalation comprising betamimetics and an anticholinergic agent
05/22/2012CA2532089C Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
05/22/2012CA2531064C Novel heteroaryl derivative
05/22/2012CA2508069C Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
05/22/2012CA2504317C Sustained release of antiinfectives
05/22/2012CA2503722C Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
05/22/2012CA2501805C Novel taxanes and methods related to use and preparation thereof
05/22/2012CA2492832C Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
05/22/2012CA2491296C Methods for treating psychosis associated with interferon-.alpha. therapy
05/22/2012CA2479005C Amorphous atorvastatin calcium or pravastatin sodium hmg-coa reductase inhibitors of desired particle size
05/22/2012CA2459033C Methods for inhibiting cognitive deterioration in adults with down's syndrome
05/22/2012CA2458442C Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
05/22/2012CA2456169C Methods and compositions relating to improved lentiviral vector production systems
05/22/2012CA2449013C Viral mutants that selectively replicate in targeted human cancer cells
05/22/2012CA2442326C Imidazolyl derivatives useful as histamine h3 receptor ligands
05/22/2012CA2440884C Transdermal patch for administering fentanyl
05/22/2012CA2436107C Kyberdrug as autovaccines with immune-regulating effects
05/22/2012CA2406024C Methods for improving size and appearance of a wound
05/22/2012CA2386865C Diagnosis and therapy of cancer using sgp28-related molecules
05/22/2012CA2374964C Process for producing an injectable medicament preparation
05/22/2012CA2304254C Trimerising module
05/21/2012DE202008018253U1 Kosmetische und pharmazeutische Anwendungen von N-Acethylhydroxyprolin Cosmetic and pharmaceutical applications of N-Acethylhydroxyprolin
05/18/2012WO2012065182A2 Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
05/18/2012WO2012065139A2 Entpd5 inhibitors
05/18/2012WO2012065110A2 S-protected cysteine analogs and related compounds
05/18/2012WO2012065102A2 S-t-butyl protected cysteine di-peptide analogs and related compounds
05/18/2012WO2012065065A1 Methods and compositions for modulating hair growth, wound healing and scar revision
05/18/2012WO2012065062A1 Novel antiviral compounds
05/18/2012WO2012065057A2 Phosphatidylinositol 3-kinase inhibitors and methods of their use
05/18/2012WO2012065054A1 Infection detection methods and systems and related compounds and compositions
05/18/2012WO2012065051A1 Compositions and methods for treating androgen receptor dependent disorders including cancers
05/18/2012WO2012065050A1 22-haloacetoxy-homopregnacalciferol analogs and their uses
05/18/2012WO2012065049A1 Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
05/18/2012WO2012065022A2 Spiro-oxindole mdm2 antagonists
05/18/2012WO2012065021A1 Dexamethasone combination therapy
05/18/2012WO2012065019A2 Pyridopyrimidinone inhibitors of p13k alpha
05/18/2012WO2012064981A2 Methods to test allergic conditions
05/18/2012WO2012064973A2 Heterocyclic compounds and uses thereof
05/18/2012WO2012064943A2 Metalloenzyme inhibitor compounds
05/18/2012WO2012064928A1 Methods and compositions for treating thyroid hormone related disorders
05/18/2012WO2012064923A2 Compounds and methods for treating multiple sclerosis
05/18/2012WO2012064914A2 Peptidomimetic inhibitors of psma
05/18/2012WO2012064911A1 Piperidinone carboxamide indane cgrp receptor antagonists
05/18/2012WO2012064910A1 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/18/2012WO2012064897A2 Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use
05/18/2012WO2012064892A1 Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
05/18/2012WO2012064887A1 Inhibitors of desumoylation enzymes and methods for their use
05/18/2012WO2012064838A1 Crystalline solids of a metap-2 inhibitor and methods of making and using same
05/18/2012WO2012064824A1 Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes
05/18/2012WO2012064815A1 Substituted azaindazole compounds
05/18/2012WO2012064808A1 Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses
05/18/2012WO2012064807A1 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
1 ... 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 ... 7860